| Filed On | Filing |
|---|---|
| 14 Feb 2020 |
Form 5: Hoeiland Jesper, Director
Holds 14,821 shares of Common Stock |
| 13 Feb 2019 |
Form 5: Hoeiland Jesper, Director
Holds 13,567 shares of Common Stock |
| 13 Feb 2019 |
Form 5: Hatzis-Schoch Brent, Sr. VP, General Counsel
Holds 2,944 shares of Common Stock |
| 13 Feb 2019 |
Form 5: Hattersley Gary, Chief Scientific Officer
Holds 1,173 shares of Common Stock |
| 13 Feb 2019 |
Form 5: Fitzpatrick Lorraine A., Chief Medical Officer
Holds 989 shares of Common Stock |
| 06 Feb 2018 |
Form 5: Snow David P., Chief Commercial Officer
Holds 6,448 shares of Common Stock |
| 05 Feb 2018 |
Form 5: Fitzpatrick Lorraine A., Chief Medical Officer
Holds 707 shares of Common Stock |
| 05 Feb 2018 |
Form 5: Hattersley Gary, Chief Scientific Officer
Holds 507 shares of Common Stock |
| 02 Feb 2012 |
Form 5: Brookside Capital Management Llc, 10% owner and 2 others
Acquired 40,940 Series A-1 Convertible Preferred Stock (Open Market Purchase) ($3.33M) · Acquired 40,940 Series A-1 Convertible Preferred Stock (Open Market Purchase) ($3.33M) |
Loading...